Scientech Research »

Perspective Therapeutics shares owned by Scientech Research

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Scientech Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $50k 12k 4.17

More positions owned by Scientech Research

Applied Digital Corp Com New (APLD)
Wave Life Sciences SHS (WVE)
Echostar Corp Cl A (SATS)
Themes Etf Tr Leverage Shs 2x (CRCG)
Scholar Rock Hldg Corp (SRRK)
Miragen Therapeutics (VRDN)
Figma Class A Com Stk (FIG)
Century Aluminum Company (CENX)
Oklo Com Cl A (OKLO)
Coinbase Global Com Cl A (COIN)
Five Below (FIVE)
Cytomx Therapeutics (CTMX)
Graniteshares Etf Tr 2x Long Coin Dai (CONL)
Snowflake Com Shs (SNOW)
Planet Labs Pbc Com Cl A (PL)

View all positions for Scientech Research

Top funds holding Perspective Therapeutics

TCG Crossover Management
Commodore Capital
Avidity Partners Management
BlackRock
Opaleye Management
Vanguard Capital Management
Millennium Management
Citadel Advisors
Vanguard Group
Balyasny Asset Management
Morgan Stanley
Geode Capital Management
Patient Square Capital
Nicholson Wealth Management Group
Goldman Sachs Group

View all funds holding Perspective Therapeutics